SCHEMBL25600405

SCHEMBL25600405

CCCCCC(C)CCNCC(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACE2 Q9BYF1 1/20 0.41
LMNA P02545 2/20 0.41
EPHX1 P07099 2/20 0.39
ADH1B P00325 2/20 0.38
ADH1C P00326 2/20 0.38
ADH1A P07327 2/20 0.38
ADH4 P08319 2/20 0.38
ADH7 P40394 2/20 0.38
OPRM1 P35372 1/20 0.38
ALDH1A1 P00352 2/20 0.37
TSHR P16473 2/20 0.37
CYP3A4 P08684 1/20 0.34
PRKD3 O94806 1/20 0.33
PRKCG P05129 1/20 0.33
PRKCB P05771 1/20 0.33
PRKCA P17252 1/20 0.33
PRKCH P24723 1/20 0.33
PRKCI P41743 1/20 0.33
PRKCE Q02156 1/20 0.33
PRKCQ Q04759 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22755788 0.86 ACE2 (0.40) ACE2LMNAEPHX1ADH1BADH1C
SCHEMBL17088076 0.85 TSHR (0.39) EPHX1ADH1BADH1CADH1AALDH1A1
SCHEMBL19423383 0.84 OPRM1 (0.45) ACE2LMNAADH1BADH1CADH1A
SCHEMBL24764379 0.82 LMNA (0.39) ACE2LMNAEPHX1ADH1BADH1C
SCHEMBL25881999 0.82 LMNA (0.39) ACE2LMNAEPHX1ADH1BADH1C
SCHEMBL22854544 0.81 ACE2 (0.47) ACE2LMNAEPHX1ADH1BADH1C
SCHEMBL21509216 0.81 TSHR (0.48) ACE2LMNAEPHX1ADH1BADH1C
SCHEMBL24673884 0.81 ACE2 (0.47) ACE2LMNAEPHX1ADH1BADH1C
SCHEMBL22701029 0.81 ACE2 (0.47) ACE2LMNAEPHX1ADH1BADH1C
SCHEMBL12512079 0.81 ADH1B (0.44) ACE2LMNAEPHX1ADH1BADH1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4194457-A1 COMPOUND FOR TARGETING AND DEGRADING PROTEIN, AND PREPARATION METHOD THEREFOR AND USE THEREOF Shanghai Leadingtac Pharmaceutical Co., Ltd. (CN) 2023-06-14 EP disclosed